NCT00002813View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

August 31, 1997

Primary Completion Date

October 31, 2004

Conditions
Cervical Cancer
Interventions
DRUG

cisplatin

DRUG

vinorelbine tartrate

Trial Locations (9)

12208

Cancer Center of Albany Medical Center, Albany

21231

Johns Hopkins Oncology Center, Baltimore

29303

CCOP - Upstate Carolina, Spartanburg

37203

Brookview Research, Inc., Nashville

48106

CCOP - Ann Arbor Regional, Ann Arbor

77030

University of Texas - MD Anderson Cancer Center, Houston

92868

Chao Family Comprehensive Cancer Center, Orange

96813

MBCCOP - Hawaii, Honolulu

27157-1082

Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00002813 - Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer | Biotech Hunter | Biotech Hunter